Form 4 for ALT Altimmune, Inc.
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-31 · accession 0001104659-23-000469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-03 | 2022-12-31 | ALT | Eisenstadt Richard I | CFO | M - OptEx | $0.00 | +12.5K | 13.9K | +915% | $0 |
| D | 2023-01-03 | 2022-12-31 | ALT | Eisenstadt Richard I | CFO | F - Tax | $16.45 | -3,028 | 10.8K | -22% | -$49.8K |
| D | 2023-01-03 | 2022-12-31 | ALT | Eisenstadt Richard I | CFO | M - OptEx | $0.00 | -12.5K | 37.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2022-12-31 | M | A | 12,500 | $0.00 | 13,866 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. |
| 2 | Common | Common Stock, par value $0.0001 | 2022-12-31 | F | D | 3,028 | $16.45 | 10,838 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-12-31 | M | D | 12,500 | $0.00 | 37,500 | D | — · — to — | 12,500 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on December 31, 2022, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |